Oklahoma · Telemedicine
Specialized Psychiatric Care in Oklahoma
Verigrate Health provides physician-led psychiatric consultation by telemedicine to appropriate patients who are physically located in Oklahoma at the time of care. Christian S. Monsalve, M.D., personally evaluates diagnostic uncertainty, complex psychopharmacology, difficult medication histories, and situations in which symptoms, medication effects, and prior treatment response require careful distinction.
The consultation is structured around the whole clinical course rather than a single prescription or diagnosis. Recommendations may support continuing treatment, revising a regimen, clarifying unanswered questions, or considering a gradual taper. Medication reduction is pursued only when clinically appropriate and is not assumed to be the goal of care.
Scope of Consultation
A Careful Review of Diagnosis, Medication, and Clinical Context
Diagnostic clarification when earlier diagnoses conflict, symptoms persist, or treatment response does not fit the expected pattern.
Individual planning when antidepressant, benzodiazepine, sleep, stimulant, or other psychiatric medication changes require careful sequence and monitoring.
Review of benzodiazepine duration, dependence, prior withdrawal, co-prescribed medicines, current benefit, clinical risk, and readiness for change.
Reassessment of ongoing indication, adverse effects, interactions, cumulative medication burden, and whether simplification could strengthen care.
Psychiatric decision-making considered alongside sleep, metabolic health, physical health, substance use, and other medically relevant factors.
Physician consultation for alcohol-related psychiatric complexity, medication strategy, treatment response, evidence-based options, and level-of-care questions.
Medication Stewardship
Psychiatric Medication Tapering in Oklahoma
A medication taper is one possible outcome of a broader psychiatric review, not its predetermined destination. Consultation examines the original indication, benefit and burden over time, previous dose changes, withdrawal experiences, current symptoms, concurrent treatment, and the patient’s goals. When reduction is appropriate, the sequence and pace are individualized to protect stability and preserve treatments that remain useful.
Review may include escitalopram (Lexapro), sertraline (Zoloft), fluoxetine (Prozac), venlafaxine (Effexor XR), duloxetine (Cymbalta), bupropion, mirtazapine, and tricyclic antidepressants. Planning considers duration, prior benefit, withdrawal sensitivity, recurrence risk, and whether present symptoms reflect the underlying condition, medication effects, or a prior dose change.
Alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), diazepam (Valium), and related medicines are evaluated in relation to duration, dependence, prior withdrawal, concurrent prescriptions, medical risk, and ongoing benefit. If tapering is appropriate, the pace is individualized rather than imposed by a fixed protocol.
Sleep medications and hypnotics
Sleep-focused review may include zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), orexin receptor antagonists, sedating antidepressants, and other hypnotics. Recommendations distinguish insomnia itself from medication effects, rebound symptoms, withdrawal, and coexisting psychiatric concerns.
Antipsychotics, mood stabilizers, and ADHD medications
Antipsychotics, lithium and other mood stabilizers, stimulant and non-stimulant ADHD treatments, anxiolytics, adjunctive medicines, and medications used in substance-related care may also be reviewed. Complex regimens are considered as connected systems rather than isolated prescriptions.
Clinical Judgment Before Change
A simpler regimen is not automatically a safer regimen. Recommendations weigh diagnostic clarity, current benefit, adverse effects, withdrawal sensitivity, medical context, available support, and the risks of both changing and continuing treatment.
How Care Works
Physician-Led Psychiatric Consultation Across Oklahoma
Appropriate patients may receive specialized psychiatric consultation by secure telemedicine while physically located in Oklahoma at the time of the appointment. The work may focus on diagnostic clarification, a complex medication regimen, difficult treatment history, deprescribing, or a proposed taper while another clinician remains involved when appropriate. Verigrate does not represent a physical Oklahoma office and is not an emergency or walk-in service; availability depends on clinical fit and practice capacity.
Practice Structure
Common Questions
Can patients in Oklahoma receive psychiatric consultation by telemedicine?
Yes. Verigrate provides physician-led psychiatric consultation by secure telemedicine to appropriate patients who are physically located in Oklahoma at the time of care. The practice does not claim a physical Oklahoma office, hospital affiliation, or walk-in service.
When can a complex medication review be helpful?
It may be helpful when several medications have been tried, treatment effects are difficult to interpret, adverse effects or interactions are concerning, prior withdrawal has complicated changes, or the diagnosis and next treatment step remain uncertain.
Can antidepressant or benzodiazepine tapering be considered?
Yes. Tapering may be considered after reviewing indication, duration, prior benefit, dependence or withdrawal history, current symptoms, concurrent treatment, medical factors, and the patient’s goals. A recommendation to reduce is never automatic.
Will consultation always lead to a medication change?
No. A useful consultation may support continuing the current regimen, obtaining additional information, clarifying the diagnosis, changing one part of treatment, postponing a taper, or developing a gradual reduction plan. The recommendation follows the clinical evidence rather than a predetermined outcome.
How does an initial Oklahoma consultation begin?
It begins with the central questions and a detailed review of symptoms, prior diagnoses, medication sequence, treatment response, withdrawal experiences, relevant medical factors, and available records. Dr. Monsalve then discusses what can be clarified and which next steps are clinically appropriate.